ADVISORY BOARD

This program's development has been guided by the input of an advisory board, whose members represent a cross-section of the professional community and include representatives from the industry, U.S. Food and Drug Administration and various research organizations.

Linda Bakke, Research Trials Office Director, Fred Hutchinson Cancer Research Center

Priya Bondre, Regulatory Affairs, Bio-Rad Laboratories (Redmond, WA)

Charles Breen, District Director, U.S. Food and Drug Administration

Lizabeth Cardwell, Principle, Compliance Consulting

Janet Christensen, Vice President, AVI Biopharma

Celeste Corcoran, Director, Investigations Branch, U.S. Food and Drug Administration, Seattle District

Nancy Dunn, Grant and Contract Coordinator (retired), Grant and Contract Services, University of Washington

Donna Edgerton, Director, Clinical Operations, Sonus Pharmaceuticals

Scott Emerson, Professor, Biostatistics, University of Washington

David Emery, Research Associate Professor, Medicine/Medical Genetics, University of Washington

Martha Feldman, R.A.C., President, Drug & Dev Co., Inc., Past President , Organization of Regulatory & Clinical Associates (ORCA)

Thomas Fleming, Professor and Chairman, Biostatistics, University of Washington

Jacqueline Gardner, Professor, Pharmacy, University of Washington

Daina Graham, Vice President, Regulatory Affairs and Quality Assurance SonoSite, Inc.

Russell Gripp, Director, Compliance Branch, U.S. Food and Drug Administration, Seattle District

Thomas Hazlet, Associate Professor, Pharmacy, University of Washington

Michael Hoffman, Principle, Regulatory and Quality Consulting

Cindy Jacobs, M.D., Executive Vice President and Chief Medical Officer, OncoGeneX

Erica Jonlin, Research Scientist, Division of Hematology, University of Washington

Richard Kronmal, Professor, Biostatistics, University of Washington

Ella Mae Kurashige, R.N., M.S.N., Manager, Patient Education/Outcomes and Patient and Family Resource Center, Harborview Medical Center

Anna Mastroianni, Associate Professor, University of Washington School of Law

Ruth McBride, Scientific Director, Axio Research Corp.

Richard Meeks, HIPAA Compliance Officer, University of Washington Medicine

Sharon O'Grady, Manager, Clinical Research, Medtronic Physio-Control

Michael Owen, Regulatory/Counterterrorism Microbiologist, U.S. Food and Drug Administration Pacific, Regional Laboratory Northwest

David Pettenski, Supervisor, Medical Device Group, U.S. Food and Drug Administration, Seattle District

William Pitlick, Vice President for Product Development, Ocularis

Jeffrey Probstfield, Professor, Medicine, Cardiology, Fred Hutchinson Cancer Research Center

Ruth Scott, Chair, The Arthritis Foundation, Pacific Northwest Chapter

Danny Shen, Professor and Chairman, Pharmacy; Professor, Pharmaceutics, University of Washington

Gigi Streidl, Clinical Trials Administrative Manager, Office of the Dean of Medicine, University of Washington

Dee Sweeney, R.A.C., Principal, Sweeney Regulatory Consulting; Past President, Organization of Regulatory and Clinical Associates (ORCA)

Terry Sweeney, Sr. Vice President, Corporate Quality and Regulatory Affairs, Philips Medical Systems

Daniel Syrdal, Attorney, Heller Erhman, L.L.P.

David Szatmary, Vice Provost, University of Washington Educational Outreach

James Young III, Project Manager, Bioprocessing Services, Berlex Laboratories, L.L.C.